 Merck Co., Inc. NYSE:MRK 2022 5th Annual Evercore ISI HealthCONx Conference Call December 1, 2022 9:40 AM ET Company Participants Peter Dannenbaum - Vice President of Investor Relations Eliav Barr - Chief Medical Officer Head of Global Clinical Development of Merck Research Laboratories Conference Call Participants Umer Raffat - Evercore ISI Umer Raffat Hello, everyone. Thank you for joining us. 